Group leaders to Freida research
[Beijing Direct News Network September 24th] (Forrida)On the afternoon of September 23, Liu Shouliang, deputy secretary of the Party committee of the group, visited Shandong furida Pharmaceutical Group Co., Ltd. (hereinafter referred to as furida Pharmaceutical Group) for investigation and discussion. Accompanied by Zhao Yanfeng, Chief Strategic Officer of the group, Jia Qingwen, deputy secretary of the Party committee and general manager of furida Pharmaceutical Group, and members of the leading group attended the meeting.
During the forum, Liu Shouliang and his entourage, after listening to the report on the completion of economic indicators, progress of key tasks and work plan for the fourth quarter of Freida Pharmaceutical Group, affirmed the work of Freida. They believed that the company's business development was relatively fast, foreign cooperation had made breakthroughs, and the popularity and reputation of the enterprise were constantly improved, which contributed to the development of the group. The specific requirements for the next step of work are put forward. Firstly, we should strengthen internal coordination, integrate resources with the Research Institute of internal medicine and related industries of the group, so as to promote the rapid development of the big health industry; secondly, we should do a good job in the third round of emancipating the mind, benchmarking with the world-class and domestic first-class enterprises, continuously improving the management level and expanding new business areas; Third, we should continue to do a good job in safety work, do a good job in safety inspection, timely discover and eliminate potential accidents, and ensure zero accidents in production safety.